Benzinga | Sep 8, 2021 04:03PM EDT

Tenaya Therapeutics Q2 EPS $(13.26) Down From $(9.21) YoY

Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(13.26) per share. This is a 43.97 percent decrease over losses of $(9.21) per share from the same period last year.